Consumer healthcare giant Johnson & Johnson (J&J) has confirmed that it was pulling some versions of infant Tylenol off store shelves in the United States due to problems with new design of the bottles.
The company said it would recall all of the 574,000 redesigned bottles of grape-flavored liquid infant Tylenol.
The redesigned bottles of infant Tylenol included a plastic cover that was designed to make it easier for parents to extract the correct dose of the medicine with a plastic syringe.
But some parents complained that when they slotted the syringe into the top of the bottle, it shoved the cover right into the bottle, making it complicated to gauge the right quantity of the medicine.
Chief executive William Weldon claimed that was nothing incorrect with the medicine itself and that the company issued the latest recall to preserve and reinforce the company’s commitment to patients and consumers.
Since 2009, J&J has issued several recalls, pulling millions of bottles of Tylenol, Benadryl and Motrin off the store shelves due to problems such as metal shavings found in medicines, bad odors and wrong levels of an active ingredient.
- Key Interest Rates Unaltered and Mortgages Get Cheaper
- November Home Sale Prices Moved up in November by 5.3 Percent
- Hyatt’s Malware Attack Affects Properties in India too
- London’s Expensive Property Market Advertises Cheapest Flat for about £75,000
- Slow Down in Housing Market Could be a Drag on Canada’s Economy
- Record Profit for American Airlines in 2015
- Soft Patch for the U.S. Economy in 2015, Q4 with Inventory Stockpile and Slowing Global Demand
- Oil Futures Scale on Hopes of Reduced Supply as Russia Plans to Talk to OPEC Members
- Amazon’s Quarterly Result Misses Expectations; Shares Drop
- Social media to blame for sleep disturbances, study